-
Smith Family support inspires others to help speed multiple myeloma research
Paul Richardson has found an important partner in Robert and Dana Smith, who recently made a $3 million gift to continue supporting his advanced MM clinical trials research.
-
Edward P. Evans Foundation takes aim at blood disorders
The Edward P. Evans Foundation has awarded $1.65 million in grants to three Dana-Farber researchers studying a group of conditions caused by malfunctioning bone marrow.
-
Rare eye cancer is focus of new fellowship
Jonathan and Shelley Isaacson have made a $1 million gift to establish Dana-Farber’s first fellowship dedicated to the study of the disease, The Isaacson Family Fellowship in Ocular Melanoma.
-
John T. Foundation supports glioblastoma research
Well-known and well-loved by family and in the community, John T. DiLiegro Jr. passed away from glioblastoma, a highly aggressive and common brain tumor, in 2022 at age 49. In his memory, his sister Karen DiLiegro formed the John T. Foundation and raised funds to support research by David Reardon, MD.
-
Robert and Margaret King
Robert and Margaret King made a gift of $100,000, supporting melanoma research under the direction of Megan Insco, MD, PhD. Their generous donation advances critical studies in the development of novel therapeutic approaches for the most difficult-to-treat melanomas, while enhancing clinical care for patients affected by this challenging disease.
-
Estate gift accelerates cancer care and research for years to come
Out of gratitude for the excellent care received by his late wife, Gerry Martineau left a generous bequest to support research and patient care at Dana-Farber.
-
Grants spur progress in personalized vaccine and rare lung cancer
California-based Troper Wojcicki Foundation provides nearly $2.2 million to advance innovation at Dana-Farber,
-
Conquer Cancer fuels five groundbreaking studies
Conquer Cancer®, the ASCO Foundation, is accelerating discovery Institute-wide, from pediatrics to rare sarcomas.
-
Sajni Fund raises vital funds for rare pediatric cancer research
Funds raised help to advance personalized immunotherapy for DIPG, a rare and aggressive pediatric brain tumor.
-
Dordick Trial College surpasses $1 million
The event offers trial lawyers and law firms a unique opportunity to network and learn from industry leaders while helping to combat Waldenström’s macroglobulinemia.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.
Please note that some translations using Google Translate may not be accurately represented and downloaded documents cannot be translated. Dana-Farber and the Jimmy Fund assume no liability for inaccuracies that may result from using this third-party tool, which is for website translation.